SCHEMBL20636640

SCHEMBL20636640

COC(=O)c1cc(B2OC(C)(C)C(C)(C)O2)c(C)c(C)c1F

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UCHL1 P09936 1/20 0.34
LIPE Q05469 3/20 0.32
SOS1 Q07889 1/20 0.32
MYC P01106 1/20 0.31
MAPT P10636 2/20 0.31
JAK2 O60674 1/20 0.31
BTK Q06187 1/20 0.31
KDM4E B2RXH2 2/20 0.31
ALDH1A1 P00352 2/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
ALOX15 P16050 1/20 0.31
TSHR P16473 1/20 0.31
HSD17B10 Q99714 1/20 0.31
CA12 O43570 2/20 0.30
CA1 P00915 2/20 0.30
CA2 P00918 2/20 0.30
CA7 P43166 2/20 0.30
CA9 Q16790 2/20 0.30
CA14 Q9ULX7 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31092591 0.92 UCHL1 (0.34) UCHL1LIPESOS1MYCMAPT
SCHEMBL29570855 0.87 UCHL1 (0.34) UCHL1LIPESOS1MYCMAPT
SCHEMBL17201213 0.86 UCHL1 (0.33) UCHL1LIPESOS1MYCMAPT
SCHEMBL17201112 0.84 UCHL1 (0.34) UCHL1MYCMAPTKDM4EALDH1A1
SCHEMBL30153179 0.83 UCHL1 (0.36) UCHL1LIPEMYCMAPTJAK2
SCHEMBL16034782 0.83 UCHL1 (0.36) UCHL1LIPEMYCMAPTJAK2
SCHEMBL20477784 0.83 KDM4E (0.39) UCHL1MAPTKDM4EALDH1A1GAA
SCHEMBL20636622 0.83 KDM4E (0.37) UCHL1MAPTKDM4EALDH1A1GAA
SCHEMBL18107886 0.82 CA12 (0.37) UCHL1MAPTKDM4EALDH1A1GAA
SCHEMBL31394282 0.81 KDM4E (0.35) UCHL1LIPESOS1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3428150-B1 AROMATIC RING COMPOUND HAVING A CHOLINERGIC MUSCARINE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATOR ACTIVITY TAKEDA PHARMACEUTICALS CO (JP) 2023-07-12 EP disclosed
US-10548877-B2 Aromatic ring compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2020-02-04 US disclosed
US-20190083467-A1 AROMATIC RING COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2019-03-21 US disclosed
EP-3428150-A1 AROMATIC RING COMPOUND Takeda Pharmaceutical Company Limited (JP) 2019-01-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190083467-A1 AROMATIC RING COMPOUND CHRM1, CHRM2, CHRM4 UCHL1 1506/4885LIPE 4086/4885SOS1 1464/4885
US-10548877-B2 Aromatic ring compound CHRM1, CHRM2, CHRM4 UCHL1 1506/4885LIPE 4086/4885SOS1 1464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.